Clinical Trials

Ovarian Neoplasms

NCT07472140 2026-03-16

PARP (Poly (ADP-ribose) Polymerase) Inhibitor With or Without Angiogenesis Inhibitor in Homologous Recombination Deficient Primary Ovarian Cancer, Fallopian-Tube Cancer, or Primary Peritoneal Cancer

Phase 2/3 Recruiting

120 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05827523 2026-02-13

FOCUS / KOV-04

Phase 3 Recruiting

520 enrolled

Phase 3 Active not recruiting

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT05316181 2026-02-12

KOV-HIPEC-02R

140 enrolled

Phase NA Not yet recruiting

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT07362147 2026-01-23

Exploring the Effects of Hand and Foot Exercise Intervention in Older Adults With Gynecological Cancer Receiving Chemotherapy Improvement of Peripheral Neuropathy and Quality of Life

74 enrolled

Uterine Cervical Neoplasms, Fallopian Tube Neoplasms, Ovarian Neoplasms, Peripheral Nervous System Diseases, Vaginal Neoplasms, Endometrial Neoplasms

NCT05236686 2025-11-19

Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer

Phase NA Recruiting

94 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Lymphatic Metastasis, Ovarian Neoplasms

NCT07171528 2025-09-12

KOV-02S

80 enrolled

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT07105553 2025-08-06

NEURO-GLOVE

Phase NA Completed

76 enrolled

Phase 3 Not yet recruiting

Ovarian Neoplasms, Peripheral Nervous System Diseases, Endometrial Neoplasms

NCT07068464 2025-07-16

ICRA

682 enrolled

Ovarian Neoplasms

NCT06839144 2025-07-11

OC-POP-PT

60 enrolled

Phase 1/2 Not yet recruiting

Neoplasms, Ovarian Neoplasms

NCT06602063 2025-06-27

Surgery for Relapsed Ovarian Cancer in Precision

33 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT06879353 2025-03-19

Comparison of Single-Dose Tranexamic Acid Vs. Placebo in Ovarian Cancer Surgery

Phase NA Completed

372 enrolled

Phase 1 Not yet recruiting

Ovarian Neoplasms

NCT06846424 2025-02-26

SCT-001 CAR T Cells Therapy for Relapsed and Refractory Ovarian Cancer

24 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT05200260 2025-02-10

Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer

220 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT04846933 2025-01-16

DECIDER

Phase NA Recruiting

200 enrolled

Phase 1 Active not recruiting

Ovarian Neoplasms

NCT02521844 2024-10-08

A Study to Evaluate the Safety and Tolerability of ETC-1922159 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumours

89 enrolled

Ovarian Neoplasms, Endometrial Neoplasms

NCT05753826 2024-02-06

Adebrelimab Combined With Fuzuloparib in the Treatment of Patients With Recurrent Platinum-resistant Ovarian Cancer.

37 enrolled

Ovarian Diseases, Ovarian Neoplasms

NCT04519151 2023-06-08

Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer

GastrointestinalGynecologic

24 enrolled

NCT05597527 2022-10-28

Fluzopari Combined With Apatinib for the Neoadjuvant Treatment of Unresectable Ovarian Cancer

35 enrolled

Ovarian Neoplasms

NCT05564234 2022-10-04

Role of Laparoscopy in Assessing Resectability of Ovarian Cancer

Phase NA Completed

30 enrolled

Ovarian Neoplasms

NCT01611766 2021-06-10

Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)?

356 enrolled

Phase EARLY_PHASE1 Completed

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

NCT04461457 2020-07-08

Targeted Radiation Therapy for Ovarian Cancer: Intraperitoneal Treatment With 211-astatine-MX35 F(ab')2

12 enrolled

Ovarian Neoplasms

NCT03150121 2020-02-26

BEDOCA

Phase NA Unknown

500 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms, Cystadenocarcinoma, Serous

NCT03942068 2019-05-08

Apatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer

35 enrolled

Ovarian Neoplasms

NCT03412526 2019-04-04

Adoptive Cell Therapy Following a Reduced Intensity, Non-myeloablative, Lymphodepleting Induction Regimen in Metastatic Ovarian

15 enrolled

Ovarian Neoplasms

NCT03547375 2018-06-06

Clinical Study of Apatinib in the Treatment of Advanced Ovarian Cancer After the Failure of Standard Chemotherapy

69 enrolled

Ovarian Neoplasms

NCT01669226 2016-12-19

AICE

Phase 2 Completed

215 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT02595021 2016-07-26

Total/Subtotal Colectomy in Ovarian Cancer

80 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00532194 2015-09-23

ICON6

486 enrolled

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01880996 2015-06-11

Tai-chi / Qi-gong in Patients With Patients With Gynecological Malignancies

Phase 1/2 Withdrawn

Fatigue, Ovarian Neoplasms, Parasomnias

NCT00850772 2014-06-12

OPEN

Phase 3 Completed

109 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms, Malnutrition

NCT01654146 2012-07-31

ICON8

1,485 enrolled

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00533299 2007-09-21

Hydralazine Valproate for Ovarian Cancer

211 enrolled